Anti-HLA-A2 [BB7.2]
Invented by Prof Walter Bodmer at University of Oxford
- Datasheet
- Reviews (0)
Info
| Catalogue Number | 151297 |
| Applications | FACS IHC IF Fn |
| Antigen/Gene or Protein Targets | Human Leukocyte Antigen- A2 |
| Reactivity | Human |
| Relevance | Human Leukocyte Antigens (HLA) are highly polymorphic proteins that are involved in the presentation of antigens to the T-cell receptor. There are two classes of HLA antigens, class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). This antibody can be used for HLA typing. |
| Host | Mouse |
| Immunogen | Papain solubilised HLA-A2, |
| Subclass | IgG2b |
| Myeloma Used | P3/NS1/1-Ag4.1 |
| Recommended Growing Conditions | DMEM + 5% FCS |
| Strain | Balb/c |
| Notes |
BB7.2 fixes complement and is cytotoxic for peripheral blood leukocytes and lymphoid cell lines. Chawla et al., 2016 - BB7.2 blocked the HLAA2/T cell receptor interactions and specifically killied target cells by E75-CTL. |
| Research Area | Immunology |
References: 22 entries
Huang et al. 2016 Scientific Reports.
FACS
Gunasekaran et al. 2016. Am J Transplant. :. PMID: 27278097.
Reches et al. 2016. J Immunol. :. PMID: 27194785.
FACS
Chawla et al. 2016. Cancer Immunol Immunother. :. PMID: 27129972.
Fn
Srivastava et al. 2016. J Virol. 90(8):3913-28. PMID: 26842468.
Nayak et al. 2016. Am J Transplant. :. PMID: 27062199.
MacDonald et al. 2016. J Clin Invest. 126(4):1413-24. PMID: 26999600.
Lasso et al. 2016. PLoS One. 11(3):e0150996. PMID: 26974162.
FACS
Lasso et al. 2016. Peptides. 78:68-76. PMID: 26854383.
Srivastava et al. 2016. J Virol. :. PMID: 26842468.
FACS
Ma et al. 2016. J Immunol. :. PMID: 26792804.
FACS
Mahiti et al. 2016. MBio. 7(1):. PMID: 26787826.
FACS
Horiuchi et al. 2015. Oncol Rep. :. PMID: 26398429.
IHC IF
Dellgren et al. 2015. PLoS One. 10(8):e0135385. PMID: 26258424.
Rancan et al. 2015. PLoS Pathog. 11(6):e1004906. PMID: 26067064.
FACS
Egui et al. 2015. PLoS One. 10(3):e0122115. PMID: 25816096.
Khan et al. 2015. J Virol. :. PMID: 25878105.
Noy et al. 2015. Mol Cancer Ther. :. PMID: 25852061.
Cheent et al. 2013. Proc Natl Acad Sci U S A. 110(42):16981-6. PMID: 24082146.
Whitfield-Larry et al. 2011. Diabetes. 60(6):1726-33. PMID: 21521873.
Parham et al. 1981. Hum Immunol. 3(4):277-99. PMID: 7035415.
Brodsky et al. 1979. Immunol Rev. 47:3-61. PMID: 95015.
Add a reference
References: 22 entries
Huang et al. 2016 Scientific Reports.
FACS
Gunasekaran et al. 2016. Am J Transplant. :. PMID: 27278097.
Reches et al. 2016. J Immunol. :. PMID: 27194785.
FACS
Chawla et al. 2016. Cancer Immunol Immunother. :. PMID: 27129972.
Fn
Srivastava et al. 2016. J Virol. 90(8):3913-28. PMID: 26842468.
Nayak et al. 2016. Am J Transplant. :. PMID: 27062199.
MacDonald et al. 2016. J Clin Invest. 126(4):1413-24. PMID: 26999600.
Lasso et al. 2016. PLoS One. 11(3):e0150996. PMID: 26974162.
FACS
Lasso et al. 2016. Peptides. 78:68-76. PMID: 26854383.
Srivastava et al. 2016. J Virol. :. PMID: 26842468.
FACS
Ma et al. 2016. J Immunol. :. PMID: 26792804.
FACS
Mahiti et al. 2016. MBio. 7(1):. PMID: 26787826.
FACS
Horiuchi et al. 2015. Oncol Rep. :. PMID: 26398429.
IHC IF
Dellgren et al. 2015. PLoS One. 10(8):e0135385. PMID: 26258424.
Rancan et al. 2015. PLoS Pathog. 11(6):e1004906. PMID: 26067064.
FACS
Egui et al. 2015. PLoS One. 10(3):e0122115. PMID: 25816096.
Khan et al. 2015. J Virol. :. PMID: 25878105.
Noy et al. 2015. Mol Cancer Ther. :. PMID: 25852061.
Cheent et al. 2013. Proc Natl Acad Sci U S A. 110(42):16981-6. PMID: 24082146.
Whitfield-Larry et al. 2011. Diabetes. 60(6):1726-33. PMID: 21521873.
Parham et al. 1981. Hum Immunol. 3(4):277-99. PMID: 7035415.
Brodsky et al. 1979. Immunol Rev. 47:3-61. PMID: 95015.
Add a reference
References: 22 entries
Huang et al. 2016 Scientific Reports.
FACS
Gunasekaran et al. 2016. Am J Transplant. :. PMID: 27278097.
Reches et al. 2016. J Immunol. :. PMID: 27194785.
FACS
Chawla et al. 2016. Cancer Immunol Immunother. :. PMID: 27129972.
Fn
Srivastava et al. 2016. J Virol. 90(8):3913-28. PMID: 26842468.
Nayak et al. 2016. Am J Transplant. :. PMID: 27062199.
MacDonald et al. 2016. J Clin Invest. 126(4):1413-24. PMID: 26999600.
Lasso et al. 2016. PLoS One. 11(3):e0150996. PMID: 26974162.
FACS
Lasso et al. 2016. Peptides. 78:68-76. PMID: 26854383.
Srivastava et al. 2016. J Virol. :. PMID: 26842468.
FACS
Ma et al. 2016. J Immunol. :. PMID: 26792804.
FACS
Mahiti et al. 2016. MBio. 7(1):. PMID: 26787826.
FACS
Horiuchi et al. 2015. Oncol Rep. :. PMID: 26398429.
IHC IF
Dellgren et al. 2015. PLoS One. 10(8):e0135385. PMID: 26258424.
Rancan et al. 2015. PLoS Pathog. 11(6):e1004906. PMID: 26067064.
FACS
Egui et al. 2015. PLoS One. 10(3):e0122115. PMID: 25816096.
Khan et al. 2015. J Virol. :. PMID: 25878105.
Noy et al. 2015. Mol Cancer Ther. :. PMID: 25852061.
Cheent et al. 2013. Proc Natl Acad Sci U S A. 110(42):16981-6. PMID: 24082146.
Whitfield-Larry et al. 2011. Diabetes. 60(6):1726-33. PMID: 21521873.
Parham et al. 1981. Hum Immunol. 3(4):277-99. PMID: 7035415.
Brodsky et al. 1979. Immunol Rev. 47:3-61. PMID: 95015.
Add a reference
Have you used this reagent? Share your experience by submitting a review and help your fellow scientists.
Review this reagent